Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00014638 · ClinicalTrials.gov registry record · Phase 4
Letrozole in Treating Postmenopausal Women With Metastatic Breast Cancer
A Phase 4 study, sponsored by Novartis.
- Completed
- Registry status
- Phase 4
- Development phase
NCT00014638: Completed Phase 4 study, sponsored by Novartis.
NCT00014638 is a Phase 4 study that has completed, run by Novartis. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00014638, a Phase 4 study, has completed, sponsored by Novartis.
- COMPLETED
- Registry status
- Phase 4
- Development phase
Study Summary
RATIONALE: Estrogen can stimulate the growth of cancer cells. Letrozole may fight breast cancer by reducing the production of estrogen. PURPOSE: Phase IV trial to study the effectiveness of letrozole in treating postmenopausal women who have metastatic breast cancer that has been previously treated with tamoxifen.
Interventions
- DRUG letrozole
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-01 |
| Est. Completion | 2002-03 |
| Phase | Phase 4 |
What the finished NCT00014638 record still lists
NCT00014638 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which letrozole is the first listed.
NCT00014638 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00014638 about?
NCT00014638 is a clinical study titled "Letrozole in Treating Postmenopausal Women With Metastatic Breast Cancer". RATIONALE: Estrogen can stimulate the growth of cancer cells. Letrozole may fight breast cancer by reducing the production of estrogen. PURPOSE: Phase IV trial to study the effectiveness of letrozole in treating postmenopausal women who have metastatic breast cancer that has been previously treated...
What is the current status of trial NCT00014638?
This trial is currently completed. It is a Phase 4 study. The study started on 2001-01. Estimated completion is 2002-03.
What interventions are being tested in trial NCT00014638?
The interventions under investigation include: letrozole (DRUG).
Who is sponsoring clinical trial NCT00014638?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia